23andMe relaunches in the US with FDA-approved health reports
23andme.com16 points·by joecackler··0 comments
Genetic Test Maker 23andMe Launches Drug R&D Effort
nytimes.com4 points·by joecackler··0 comments
23andMe raises $50M, cuts price to $99, sets goal of 1M genotyped customers
blog.23andme.com305 points·by joecackler··236 comments